List of Tables
Table 1. Global Gene Therapy For Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Rb Gene
Table 3. Key Players of P53 Gene
Table 4. Key Players of APC Gene
Table 5. Key Players of NF1 Gene
Table 6. Key Players of Others
Table 7. Global Gene Therapy For Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Gene Therapy For Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Gene Therapy For Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Gene Therapy For Cancer Market Share by Region (2020-2025)
Table 11. Global Gene Therapy For Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Gene Therapy For Cancer Market Share by Region (2026-2031)
Table 13. Gene Therapy For Cancer Market Trends
Table 14. Gene Therapy For Cancer Market Drivers
Table 15. Gene Therapy For Cancer Market Challenges
Table 16. Gene Therapy For Cancer Market Restraints
Table 17. Global Gene Therapy For Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Gene Therapy For Cancer Market Share by Players (2020-2025)
Table 19. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Cancer as of 2024)
Table 20. Ranking of Global Top Gene Therapy For Cancer Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Gene Therapy For Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Gene Therapy For Cancer, Headquarters and Area Served
Table 23. Global Key Players of Gene Therapy For Cancer, Product and Application
Table 24. Global Key Players of Gene Therapy For Cancer, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Therapy For Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Gene Therapy For Cancer Revenue Market Share by Type (2020-2025)
Table 28. Global Gene Therapy For Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Gene Therapy For Cancer Revenue Market Share by Type (2026-2031)
Table 30. Global Gene Therapy For Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Gene Therapy For Cancer Revenue Market Share by Application (2020-2025)
Table 32. Global Gene Therapy For Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Gene Therapy For Cancer Revenue Market Share by Application (2026-2031)
Table 34. North America Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Gene Therapy For Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Gene Therapy For Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Gene Therapy For Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Gene Therapy For Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Gene Therapy For Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Gene Therapy For Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Gene Therapy For Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 49. GLIEAD Company Details
Table 50. GLIEAD Business Overview
Table 51. GLIEAD Gene Therapy For Cancer Product
Table 52. GLIEAD Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 53. GLIEAD Recent Development
Table 54. REGENXBIO Company Details
Table 55. REGENXBIO Business Overview
Table 56. REGENXBIO Gene Therapy For Cancer Product
Table 57. REGENXBIO Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 58. REGENXBIO Recent Development
Table 59. Autolus Company Details
Table 60. Autolus Business Overview
Table 61. Autolus Gene Therapy For Cancer Product
Table 62. Autolus Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 63. Autolus Recent Development
Table 64. American Gene Technologies Company Details
Table 65. American Gene Technologies Business Overview
Table 66. American Gene Technologies Gene Therapy For Cancer Product
Table 67. American Gene Technologies Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 68. American Gene Technologies Recent Development
Table 69. Arcellx Company Details
Table 70. Arcellx Business Overview
Table 71. Arcellx Gene Therapy For Cancer Product
Table 72. Arcellx Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 73. Arcellx Recent Development
Table 74. AUSTRIANOVA Company Details
Table 75. AUSTRIANOVA Business Overview
Table 76. AUSTRIANOVA Gene Therapy For Cancer Product
Table 77. AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 78. AUSTRIANOVA Recent Development
Table 79. Alphavax Company Details
Table 80. Alphavax Business Overview
Table 81. Alphavax Gene Therapy For Cancer Product
Table 82. Alphavax Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 83. Alphavax Recent Development
Table 84. Cellectis Company Details
Table 85. Cellectis Business Overview
Table 86. Cellectis Gene Therapy For Cancer Product
Table 87. Cellectis Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 88. Cellectis Recent Development
Table 89. Chimeron Company Details
Table 90. Chimeron Business Overview
Table 91. Chimeron Gene Therapy For Cancer Product
Table 92. Chimeron Revenue in Gene Therapy For Cancer Business (2020-2025) & (US$ Million)
Table 93. Chimeron Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Gene Therapy For Cancer Picture
Figure 2. Global Gene Therapy For Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy For Cancer Market Share by Type: 2024 VS 2031
Figure 4. Rb Gene Features
Figure 5. P53 Gene Features
Figure 6. APC Gene Features
Figure 7. NF1 Gene Features
Figure 8. Others Features
Figure 9. Global Gene Therapy For Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Gene Therapy For Cancer Market Share by Application: 2024 VS 2031
Figure 11. Cancer Treatment Case Studies
Figure 12. Tissue Repair Case Studies
Figure 13. Others Case Studies
Figure 14. Gene Therapy For Cancer Report Years Considered
Figure 15. Global Gene Therapy For Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Gene Therapy For Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Gene Therapy For Cancer Market Share by Region: 2024 VS 2031
Figure 18. Global Gene Therapy For Cancer Market Share by Players in 2024
Figure 19. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Cancer as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Gene Therapy For Cancer Revenue in 2024
Figure 21. North America Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Gene Therapy For Cancer Market Share by Country (2020-2031)
Figure 23. United States Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Gene Therapy For Cancer Market Share by Country (2020-2031)
Figure 27. Germany Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Gene Therapy For Cancer Market Share by Region (2020-2031)
Figure 35. China Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Gene Therapy For Cancer Market Share by Country (2020-2031)
Figure 43. Mexico Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Gene Therapy For Cancer Market Share by Country (2020-2031)
Figure 47. Turkey Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Gene Therapy For Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GLIEAD Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 51. REGENXBIO Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 52. Autolus Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 53. American Gene Technologies Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 54. Arcellx Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 55. AUSTRIANOVA Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 56. Alphavax Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 57. Cellectis Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 58. Chimeron Revenue Growth Rate in Gene Therapy For Cancer Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
